Regulatory and clinical considerations for biosimilar oncology drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulatory and clinical considerations for biosimilar oncology drugs

Published:2014-12 Issue:13 Volume:15 Page:e594-e605
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bennett Charles L,Chen Brian,Hermanson Terhi,Wyatt Michael D,Schulz Richard M,Georgantopoulos Peter,Kessler Samuel,Raisch Dennis W,Qureshi Zaina P,Lu Z Kevin,Love Bryan L,Noxon Virginia,Bobolts Laura,Armitage Melissa,Bian John,Ray Paul,Ablin Richard J,Hrushesky William J,Macdougall Iain C,Sartor Oliver,Armitage James O

Publisher

Elsevier BV

Subject

Oncology

Reference48 articles.

1. Will biosimilars gain momentum?;Hirsch;J Natl Compr Canc Netw,2013

2. Bending the cost curve in cancer care;Smith;N Engl J Med,2011

3. Developing the nation's biosimilars program;Kozlowski;N Engl J Med,2011

4. Development and regulation of biosimilars: current status and future challenges;Tsiftsoglou;BioDrugs,2013

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of perceived value dimensions on customer brand loyalty towards luxury cars;Rajagiri Management Journal;2024-06-13

2. Biosimilars in Blood Cancer;Biosimilars for Cancer Treatment;2024

3. Delivery of biologics: Topical administration;Biomaterials;2023-11

4. Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021;JCO Oncology Practice;2023-10

5. Maximizing the benefits of using biosimilars in Egypt;Journal of Pharmaceutical Policy and Practice;2023-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP